Home sleep test vs in-lab study: what's the difference?

What's the difference between a home sleep test and an in-lab sleep study?

The two differ in three ways: where the night happens, how many signals get recorded, and whether anyone is watching. Ontario Health's 2024 health technology assessment lays out the sleep study levels in a single table. A level 1 study takes place "In a laboratory, a fully attended" and monitors "≥ 7" parameters. A level 2 study records the same seven-plus parameters, brain activity included, but runs "At home, unattended", with a technician who "may set up the equipment". A level 3 test records "≥ 3" parameters at home, unattended. A level 4 device records "≥ 1" and is listed for "Screening for obstructive sleep apnea". The same assessment cautions that there are "no official standard definitions for these levels", so the phrase "home sleep test" on a clinic's page does not by itself say which of level 2, 3 or 4 is on offer.

What that means channel by channel: level 1 and level 2 both carry oxygen saturation, airflow, respiratory effort, brain activity via EEG, heart activity via ECG, eye movement via EOG, and muscle activity via EMG at the chin and leg, with body position and synchronized video available. A level 3 test carries oxygen, airflow, respiratory effort and heart rate. A level 4 device records oxygen alone. The American Academy of Sleep Medicine uses older Type I–IV labels for the same idea, noting that "Type II studies use the same monitoring sensors as full PSGs (Type I) but are unattended", while Type III devices "measure limited cardiopulmonary parameters".

SleepClinicFinder records which Ontario clinics publish that they offer a home sleep test and which publish attended in-lab testing, because the clinic's own wording is the only reliable way to know what a given lab actually runs. If a clinic's page says only "sleep study", the level is worth asking about directly. The guideline also sets a floor for what counts as usable home data: a technically adequate device "incorporates a minimum of the following sensors: nasal pressure, chest and abdominal respiratory inductance plethysmography, and oximetry; or else PAT with oximetry and actigraphy", and the recording needs "a minimum of 4 hours of technically adequate oximetry and flow data".

Are at-home sleep tests as accurate as in-lab studies?

Accuracy has been measured, and the published answer depends heavily on which home test and which patients. A Canadian meta-analysis in CMAJ compared level 3 portable devices against level 1 polysomnography and reported that "The estimated area under the receiver operating characteristics curve was high, ranging between 0.85 and 0.99 across different levels of disease severity", with "Summary sensitivity ranged between 0.79 and 0.97, and summary specificity ranged between 0.60 and 0.93 across different apnea–hypopnea cut-offs". The authors' own framing of that result is narrow: level 3 devices "showed good diagnostic performance compared with level 1 sleep tests in adult patients with a high pretest probability of moderate to severe obstructive sleep apnea and no unstable comorbidities".

For level 2 — the full at-home polysomnogram — Ontario Health reported its own numbers with the certainty ratings attached, which matters more than the numbers alone. "For diagnosing sleep apnea in adults, based on 8 studies (N = 422), the sensitivity ranged from 0.760 to 1.00 (Grading of Recommendations, Assessment, Development and Evaluations [GRADE]: Low) and the specificity ranged from 0.400 to 1.00 (GRADE: Low)." The same document reports "Failure rates were reported between 0% and 20% (GRADE: Very low)." Low-certainty evidence spanning a wide range is a different thing from a settled accuracy figure, and the report presents it that way.

Ontario Health separates the levels sharply on this point. Level 2 devices "like level 1 devices, evaluate 7 or more different parameters" but run unattended. Level 3 and level 4 testing, it says, are "used as adjunct diagnostic tools for obstructive sleep apnea (for confirmation or to rule-in a diagnosis) and are not intended to be replacements for level 1 testing". So the honest version of the accuracy question is a question about which level, measured in whom — and that is a determination the referring physician makes, not a directory. SleepClinicFinder never rates one test against another; where a clinic publishes that it offers a home sleep test, the listing records that claim and nothing more.

Why would an at-home test miss sleep apnea that a lab study finds?

There is a specific measurement reason, and it is well documented. Most home devices do not record the channels used to stage sleep, so the arithmetic changes underneath the result. The 2017 guideline puts it plainly: "standard sleep staging channels are not typically monitored in HSAT (e.g., EEG, EOG and EMG monitoring are not typically performed), which results in use of the recording time rather than sleep time to define the denominator of the respiratory event index". Time spent awake in bed still counts as recording time. Spread the same number of breathing events over a longer denominator and the resulting index reads lower than an in-lab study's apnea–hypopnea index would.

Two further mechanisms compound it. Home devices "that use conventional sensors are unable to detect hypopneas only associated with cortical arousals", even though those events are part of the recommended scoring rule. And equipment fails when nobody is there: "Sensor dislodgement and poor quality signal during HSAT are additional contributors to the measurement error". The guideline states the combined direction of travel — "All these factors can result in the underestimation of the 'true' AHI, and may result in the need for repeated studies due to inadequate data for diagnosis." It also notes home devices carry risk of technical failure "due to a lack of real-time monitoring", and that most cannot "define sleep versus wake".

Published guidance treats that possibility directly rather than leaving it to chance. Where a single home sleep apnea test is negative, inconclusive, or technically inadequate, the 2017 guideline directs that "polysomnography be performed for the diagnosis of OSA". That sentence is written for clinicians deciding what to order next. If your home test result and your experience do not match, the productive move is to bring both to the physician who ordered the test.

Is an in-lab sleep study really the gold standard?

In the published literature, yes — and the phrase is used in exactly those words. The 2017 guideline states that "PSG is widely accepted as the gold standard test for diagnosis of OSA" and that it "has traditionally been used as the gold standard for comparison to other diagnostic tests, including HSAT". The Canadian Thoracic Society's 2011 guideline update reaches the same place with a grade attached: "Level I (complete laboratory technologist-attended PSG remains the accepted standard for evaluation of sleep disordered breathing and is the test of choice when readily available. (Grade of recommendation: 1B)". Ontario Health describes level 1 as "the current standard of care in clinical practice in Ontario today".

One reason for the status is breadth. "Besides the diagnosis of OSA, PSG can identify co-existing sleep disorders, including other forms of sleep-disordered breathing", which a limited breathing recorder is not built to see. The CMAJ meta-analysis draws the same boundary from the other direction: "For patients suspected of having other types of sleep-disordered breathing or sleep disorders not related to breathing, level 1 testing remains the reference standard."

Gold standard does not mean sole option, though, and the guidance is explicit about that too. The 2017 guideline directs that "polysomnography, or home sleep apnea testing with a technically adequate device, be used for the diagnosis of OSA in uncomplicated adult patients presenting with signs and symptoms that indicate an increased risk of moderate to severe OSA". It separately lists situations where it directs clinicians to use polysomnography rather than home testing — among them significant cardiorespiratory disease, potential respiratory muscle weakness from a neuromuscular condition, suspected sleep related hypoventilation, chronic opioid medication use, history of stroke, or severe insomnia. Those are instructions to the ordering clinician about test selection, not a checklist for a reader to self-apply. The lab's own equipment is acknowledged as a burden as well: PSG "involves cumbersome sensors and devices".

Which sleep study does OHIP cover — the home test or the in-lab one?

In Ontario the publicly funded option is the in-lab study, not the home test. Ontario Health's 2024 health technology assessment states it without hedging: "Currently, the only publicly funded option in Ontario is level 1 polysomnography, which takes place in a sleep clinic run by either a hospital or an independent health facility." The same document confirms the other side of the ledger — "Level 2 polysomnography is not publicly funded in Ontario" — and, when the authors tried to model how much at-home testing already happens, they reported they could not, "because none of unattended portable sleep studies are currently funded in Ontario". A clinic operator with GTA locations describes the same line from the front desk: "In Ontario level 1 sleep studies are covered".

On frequency, the folk claim that the public plan pays for one study per lifetime and nothing after is wrong as stated. Ontario Health, citing the Ministry of Health, records that "OHIP covers the cost of an initial diagnostic level 1 sleep-study per lifetime and repeat studies every 12 months, when deemed clinically necessary, as well as a therapeutic study every 2 years". That is a government assessment reporting the Ministry's stated rule rather than a line read out of the Schedule of Benefits, so treat it as the shape of the rule and confirm the specifics with the lab that will submit the claim.

One change is in motion and is easy to misread. In August 2024, "Ontario Health, based on guidance from the Ontario Health Technology Advisory Committee, recommend[ed] publicly funding level 2 polysomnography for the diagnosis of sleep disorders", having concluded the clinical evidence showed level 2 "was similarly accurate when compared with level 1 polysomnography". Recommended is not funded: the same document notes implementation "would likely require changes to the current reimbursement approach", including OHIP fee codes "jointly negotiated between the Ministry of Health and the Ontario Medical Association". The committee also "supports the continued availability of level 1 polysomnography in Ontario since level 2 may not be a reasonable option for everyone". Ask any clinic offering a home sleep test what it bills, and to whom, before the equipment goes home with you.

Is an in-lab sleep study cheaper or more expensive than a home test?

The forum version of this — that a lab night costs some large multiple of a home test — does not survive contact with the published analysis, and we publish no dollar figure for either test because no source gives a price an Ontario patient will actually pay. What the 2017 guideline does say is careful: "Though a single night of HSAT is less resource-intensive than a single night of PSG, the relative cost-effectiveness of management pathways that incorporate each of these diagnostic strategies is unclear." Its conclusion on the comparison is blunter still — "The available studies indicate that the potential cost advantages of HSAT over PSG are not as high as reflected by the cost difference of a single night of testing."

The reason is in the pathway rather than the price list. A home test that comes back inconclusive or technically inadequate leads to further testing, and repeated studies erode a single-night saving. In Ontario the funding split adds its own arithmetic on top: the level 1 night is publicly funded, while unattended portable studies were not funded as of the 2024 assessment. That is the opposite of the pattern people arrive expecting, and it is why the cost question in Ontario is really a coverage question. SleepClinicFinder publishes no price for either test, and where a clinic sells a home sleep test privately, the amount is a question for that clinic's front desk.

How long is the wait for each type of sleep study in Ontario?

Long enough that Ontario Health flagged it as a system problem. Its August 2024 recommendation states that "wait times in Ontario for access to sleep specialists in clinics for adults and children is currently estimated to be close to 1 year, which is longer than the Canadian Thoracic Society recommendation that all patients be seen within 6 months of referral to a sleep specialist". The Society's published targets are tighter at the urgent end: patients with suspected severe obstructive sleep apnea and those "working in safety-critical occupations should be investigated within four weeks of the referral to a diagnostic sleep facility", and all patients "within six months of the referral".

Ontario-specific cohort data fills in the texture. People who started treatment for obstructive sleep apnea in 2010 "reported having waited approximately 1 year between their initial visit and starting treatment, and limited sleep clinic availability was reported as the primary factor". The assessment adds that "Less than one-half of Ontario CPAP users underwent a sleep study within 6 months of their referral, and wait times were even longer for females, people who had been recently hospitalized, and people who accessed testing through the hospital (as opposed to those who accessed testing through an independent health facility)". Access is uneven nationally too: "there are still areas of Canada with no sleep diagnostic services".

Because the wait attaches to a specific clinic's book rather than to a test type in the abstract, where you are referred matters. SleepClinicFinder lists sleep clinics city by city — Toronto, Mississauga and Brampton among them — with what each publishes about the testing it offers, including whether a home sleep test is among it, so a referral conversation can start from a real shortlist. None of this is a promise about how long any individual will wait; published estimates describe a system, not a booking.

What actually happens during an overnight lab study — and can you even sleep there?

A level 1 night is an instrumented night with staff present. Ontario Health describes what the recording captures: level 1 polysomnography "captures more than 7 parameters and informs clinicians about brain activity, eye movement, muscle activity, breathing rate and depth, and oxygen levels during sleep". In practice that means electrodes on the scalp and face for EEG and eye movement, sensors at the chin and leg for muscle activity, bands for respiratory effort, airflow sensors, a finger probe for oxygen, ECG leads, and often body position monitoring and synchronized video. The 2017 guideline acknowledges the obvious downside of all that hardware in one sentence: PSG "involves cumbersome sensors and devices that, if minimized and less obtrusive, could make PSG more tolerable for patients".

The worry about not sleeping properly in a clinic is documented rather than dismissed. Ontario Health writes that "not everyone is comfortable with the idea of sleeping in an unfamiliar clinical environment while being monitored, and if they undergo a sleep study nonetheless, their quality of sleep may not be representative of sleep in their home environment". Its preference evidence runs both ways: "Most people expressed preference for at-home studies, citing convenience and comfort as the main reasons", while "Some people expressed a preference for level 1 polysomnography, which they perceived to be more accurate; they were also concerned about setting the equipment up correctly at home." Participants also reported at-home studies were "more comfortable, convenient, and better able to reflect their normal sleep pattern".

Access barriers cut across both settings. In-clinic testing can be hard to reach for people managing "transportation; care partner responsibilities; patients with limited mobility, after stroke or spinal cord injury, or requiring dialysis equipment that cannot be easily brought to a sleep clinic". At-home testing has its own: setting up equipment unaided is described as a challenge "for people with physical limitations". And Ontario Health notes that "people with coarse and curly hair (including but not limited to people of African descent) may face barriers with electroencephalography", which is integral to both level 1 and level 2 testing. One in-lab protocol worth knowing exists: a split-night study, where diagnosis and CPAP titration happen in one night, which the guideline says should only run when "A moderate to severe degree of OSA is observed during a minimum of 2 hours of recording time" and "At least 3 hours are available to complete CPAP titration".

Can my child have a home sleep test instead of an overnight lab study?

For children the published position is unusually direct, and it points the other way from adult practice. The American Academy of Sleep Medicine's 2017 position paper states that "Use of a home sleep apnea test is not recommended for the diagnosis of obstructive sleep apnea in children", and that "The gold standard for diagnosis of OSA in children is PSG". Ontario Health's level 2 evidence for children rests on very little: "For diagnosing sleep apnea in children, based on 1 study (N = 47), sensitivity was 0.933 (GRADE: Low) and specificity was 0.969 (GRADE: Moderate)." One study of 47 children is a thin base, and the report presents it as such.

Waits for paediatric testing are longer than for adults. Ontario Health records that "Sleep study wait times for children are also estimated to be between 1 and 2 years; large variations exist throughout Canada due to access to pediatric facilities and practitioner-to-children ratios". Referral routes are worth checking individually: SickKids, for example, states referrals "must be made by a family physician or paediatrician" through its referral system rather than by a parent booking directly. Other programs set their own rules, so ask the one you are referred to.

None of that decides anything for an individual child. What test a child has is chosen by the paediatrician or the sleep program handling the referral, on grounds specific to that child. The useful preparation for that appointment is knowing the published position exists and asking how it applies to your child's situation.

What happens if my home sleep test comes back negative but I still feel exhausted?

This is common enough that the guidance addresses it as a step in the pathway rather than an anomaly. The 2017 guideline directs that where a single home sleep apnea test is negative, inconclusive, or technically inadequate, "polysomnography be performed for the diagnosis of OSA". Read alongside the measurement limits — recording time as the denominator, arousal-related hypopneas outside the reach of conventional home sensors, sensors that come loose overnight with nobody there — a negative result from a limited home test is a piece of information, not a closed file. It says what that device recorded on that night.

The guideline also closes off two shortcuts people reach for next. Repeating the home test more nights is not routinely supported — "Insufficient evidence exists to support routine performance of more than a single night's recording for HSAT." And questionnaires and apps are not a substitute for a test: clinical tools, questionnaires and prediction algorithms are directed not to be used to diagnose obstructive sleep apnea in adults "in the absence of polysomnography or home sleep apnea testing".

What is left is a conversation, and it belongs with the physician who ordered the test. Bring the report, the device type if you know it, and a plain description of what you are experiencing. SleepClinicFinder can show which clinics near you publish that they run attended in-lab studies and which publish home sleep test services, so that conversation can move quickly once a next step is decided. Nothing here says what your result means; only the clinician holding your record can.

Frequently asked questions

Sources

Every figure quoted above comes from one of the reference pages below, each fetched and quoted in full in our research file for this guide. Discussion threads are listed separately and held to a narrower standard: we could not fetch those pages, so we quote a thread’s title only — checked against the public oEmbed record for that thread on the date shown — and never a comment inside it, and never a figure. Where we could not verify a claim, we cut it rather than publish it.

1. Recommendation: Level 2 Polysomnography for the Diagnosis of Sleep Disorders (August 2024) — Ontario Health / Ontario Health Technology Advisory Committee. Fetched August 9, 2026.
2. Level 2 Polysomnography for the Diagnosis of Sleep Disorders: A Health Technology Assessment (Ont Health Technol Assess Ser 2024;24(7)) — Ontario Health. Fetched August 9, 2026.
3. Clinical Practice Guideline for Diagnostic Testing for Adult Obstructive Sleep Apnea (Kapur et al., J Clin Sleep Med 2017) — American Academy of Sleep Medicine. Fetched August 9, 2026.
4. Canadian Thoracic Society 2011 guideline update: diagnosis and treatment of sleep disordered breathing (Fleetham et al., Can Respir J 2011) — Canadian Thoracic Society. Fetched August 9, 2026.
5. Diagnostic accuracy of level 3 portable sleep tests versus level 1 polysomnography for sleep-disordered breathing (El Shayeb et al., CMAJ 2014) — Canadian Medical Association Journal. Fetched August 9, 2026.
6. AASM Position Paper for the Use of a Home Sleep Apnea Test for the Diagnosis of OSA in Children (Kirk et al., 2017) — American Academy of Sleep Medicine. Fetched August 9, 2026.
7. FAQs — are sleep tests covered by government run health plans? — MedSleep. Fetched August 9, 2026.
8. Respiratory Medicine — referrals — The Hospital for Sick Children (SickKids). Fetched August 9, 2026.